3Kozuru M, Uike N, Takahira H, et al. Immunoglobulin class switch from IgA1 to IgG2 and simultaneous a,sociation with Bence Jones proteinuria in the escape phase in a myeloma patient treated with interferon alpha[ J ]. Br J Haematol, 1997,98 : 114-118. 被引量：1
4Bartl R, Frisch B. Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS[J]. Pathologie Biologie, 1999, 47 : 158-168. 被引量：1
5San Miguel JF, Almeida J, Mateo G, et al. Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome[ J]. Blood, 2002,99 : 1853-1856. 被引量：1
6Paiva B, Vidfiales MB, Cervero J, et al. Multiparameter flow cytometry remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation [J]. Blood, 2008, 112: 4017-4023. 被引量：1
7Dispenzieri A, Zhang L, Katzmann JA, et al. Appraisal of immunoglobulin free light chain as a marker of response [ J]. Blood, 2008,111:4908-4915. 被引量：1
8Dispenzieri A, Lacy MQ, Katzmann JA, et al. Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation[ J]. Blood, 2006,107:3378-3383. 被引量：1
9Shaw GR. Nonsecretory plasma cell myeloma-becoming even more rare with serum flee light-chain assay: a brief review [ J ]. Arch Pathol Lab Med, 2006, 130:1212-1215. 被引量：1
10van Rhee F, Bolejack V, Hollmig K, et al. High serum free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis [ J ]. Blood, 2007,110:827- 832. 被引量：1
